CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 13 | 12 | −1 |
| Shares | 190.0K | 104.8K | −85.2K (−44.9%) |
| Value | $190.5K | $234.4K | +$44.0K (+23.1%) |
New holders (5)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 23,765 | $53.0K | 0.00% |
| State Street Corp | 22,556 | $50.3K | 0.00% |
| Acadian Asset Management LLC | 22,292 | $49.0K | 0.00% |
| FSM Wealth Advisors, LLC | 16,334 | $37.9K | 0.02% |
| Geode Capital Management, LLC | 16,142 | $36.0K | 0.00% |
Sold out (6)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Armistice Capital, LLC | 124,000 | $124.0K |
| Renaissance Technologies LLC | 26,800 | $27.0K |
| Citadel Advisors LLC | 13,196 | $13.2K |
| Virtu Financial LLC | 11,119 | $11.0K |
| FMR LLC | 200 | $200 |
| Gradient Investments LLC | 7 | $7 |